Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantatio...
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
About this item
Full title
Author / Creator
Publisher
Italy: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Italy: MDPI AG
Subjects
More information
Scope and Contents
Contents
Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failure and severe graft-versus-host disease (GVHD). Our...
Alternative Titles
Full title
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_63844e4d3d1742acba8ee8d340994309
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_63844e4d3d1742acba8ee8d340994309
Other Identifiers
ISSN
2036-7503,2036-749X
E-ISSN
2036-7503
DOI
10.4081/pr.2011.s2.e15
